Cholamandalam Investment and Finance Company Limited has announced a board meeting scheduled for January 30, 2026, to review and approve its quarterly financial performance. The meeting will focus on considering the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025.

Board Meeting Details

The company has formally notified both the National Stock Exchange of India Limited and BSE Limited about the upcoming board meeting under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting is scheduled to take place on Friday, January 30, 2026.

Trading Window Closure

In accordance with regulatory requirements and in connection with the impending publication of financial results, Cholamandalam Investment and Finance Company Limited has implemented a trading window closure for designated persons. This restriction will be effective from January 1, 2026, through February 1, 2026, with both dates being inclusive.

Regulatory Compliance

The company has fulfilled its disclosure obligations by informing the stock exchanges about the board meeting schedule. The notification was signed by P. Sujatha, Company Secretary, on January 2, 2026, ensuring timely communication to market participants and regulatory authorities.

The scheduled board meeting represents a routine quarterly review process where the company's directors will evaluate the financial performance for the third quarter of fiscal year 2026. Market participants and investors will await the outcome of this meeting for insights into the company's operational and financial performance during the specified period.

Cholamandalam Investment has received an updated price target from Morgan Stanley, with the global investment bank raising its target to ₹1,640 from the previous ₹1,540. The brokerage has maintained its Equal Weight rating on the financial services company.

Target Price Revision Details

The revised target price represents a notable upward adjustment in Morgan Stanley's valuation of the company. The following table summarizes the key changes:

Rating Implications

Morgan Stanley's decision to maintain the Equal Weight rating indicates the brokerage continues to view Cholamandalam Investment as fairly valued relative to its coverage universe. An Equal Weight rating typically suggests that the stock is expected to perform in line with the broader market or sector average.

The combination of an unchanged rating with an increased target price reflects Morgan Stanley's updated assessment of the company's valuation parameters while maintaining a neutral stance on relative performance expectations.

Market Context

The target price revision comes as part of Morgan Stanley's ongoing coverage of the financial services sector. The ₹100 increase in the target price suggests the brokerage has incorporated updated financial projections or valuation multiples in its analysis of Cholamandalam Investment's prospects.

The upward revision of 6.49% in the target price, from ₹1,540 to ₹1,640, indicates a positive adjustment in Morgan Stanley's outlook for Cholamandalam Investment. However, investors should note that this change in target price does not alter the overall Equal Weight rating, suggesting a balanced view on the company's potential performance relative to its peers.